Christopher J Rudnisky1, Darwin Wan2, Ezekiel Weis2. 1. Department of Ophthalmology, University of Alberta, Edmonton, Canada. Electronic address: chris@rudnisky.ca. 2. Department of Ophthalmology, University of Alberta, Edmonton, Canada.
Abstract
OBJECTIVE: To determine the 8-year incidence of endophthalmitis after cataract surgery and to determine which surgical practices were associated with higher rates of endophthalmitis. DESIGN: Case-control study. PARTICIPANTS: A total of 75 318 eyes undergoing cataract extractions, performed by 26 different surgeons at 4 public hospitals and 5 nonhospital surgical facilities. METHODS: Cases of endophthalmitis were acquired using a detailed, prospectively designed demographic database. Controls were tabulated using volume data available from the provincial health care system. MAIN OUTCOME MEASURES: The primary outcome was the development of endophthalmitis. RESULTS: A total of 23 cases (13 with culture-positive results) of postoperative endophthalmitis occurred, yielding an overall 8-year incidence of 0.03%. The incidence of endophthalmitis varied between surgeons from 0% to 0.20%. Two surgeons had higher rates than the rest of the group: 1 high-volume surgeon (1059.4±231.9 mean cases per year) with an incidence of 0.08% (n = 7; P = 0.004) and 1 low-volume surgeon (123.5±44.8 mean cases per year) with an incidence of 0.20% (n = 2; P = 0.002). On univariate analysis, the rate of endophthalmitis was not influenced by the use of intracameral (0.898) or subconjunctival antibiotics (0.331), whereas the use of moxifloxacin was associated with a lower rate of endophthalmitis (P = 0.029). Surgery at 1 private facility (P = 0.046) and the use of timolol at the end of the procedure (P = 0.007) were associated with a higher rate of endophthalmitis. Multivariate analysis demonstrated that the odds of endophthalmitis was lower if a second-generation (P = 0.02) or fourth-generation (P = 0.008) fluoroquinolone antibiotic was used after surgery. In contrast, the odds of endophthalmitis occurring was higher if timolol (P = 0.0002) was used at the end of the procedure or if the surgery was performed at one of the private facilities (P = 0.009). CONCLUSIONS: The rate of endophthalmitis was lower if a fluoroquinolone was used after surgery. In contrast, endophthalmitis was more likely to occur if timolol was used at the end of the procedure or if surgery was performed at one of the private facilities.
OBJECTIVE: To determine the 8-year incidence of endophthalmitis after cataract surgery and to determine which surgical practices were associated with higher rates of endophthalmitis. DESIGN: Case-control study. PARTICIPANTS: A total of 75 318 eyes undergoing cataract extractions, performed by 26 different surgeons at 4 public hospitals and 5 nonhospital surgical facilities. METHODS: Cases of endophthalmitis were acquired using a detailed, prospectively designed demographic database. Controls were tabulated using volume data available from the provincial health care system. MAIN OUTCOME MEASURES: The primary outcome was the development of endophthalmitis. RESULTS: A total of 23 cases (13 with culture-positive results) of postoperative endophthalmitis occurred, yielding an overall 8-year incidence of 0.03%. The incidence of endophthalmitis varied between surgeons from 0% to 0.20%. Two surgeons had higher rates than the rest of the group: 1 high-volume surgeon (1059.4±231.9 mean cases per year) with an incidence of 0.08% (n = 7; P = 0.004) and 1 low-volume surgeon (123.5±44.8 mean cases per year) with an incidence of 0.20% (n = 2; P = 0.002). On univariate analysis, the rate of endophthalmitis was not influenced by the use of intracameral (0.898) or subconjunctival antibiotics (0.331), whereas the use of moxifloxacin was associated with a lower rate of endophthalmitis (P = 0.029). Surgery at 1 private facility (P = 0.046) and the use of timolol at the end of the procedure (P = 0.007) were associated with a higher rate of endophthalmitis. Multivariate analysis demonstrated that the odds of endophthalmitis was lower if a second-generation (P = 0.02) or fourth-generation (P = 0.008) fluoroquinolone antibiotic was used after surgery. In contrast, the odds of endophthalmitis occurring was higher if timolol (P = 0.0002) was used at the end of the procedure or if the surgery was performed at one of the private facilities (P = 0.009). CONCLUSIONS: The rate of endophthalmitis was lower if a fluoroquinolone was used after surgery. In contrast, endophthalmitis was more likely to occur if timolol was used at the end of the procedure or if surgery was performed at one of the private facilities.
Authors: Randy C Bowen; Andrew Xingyu Zhou; Sailaja Bondalapati; Thomas W Lawyer; Karisa B Snow; Patrick R Evans; Tyler Bardsley; Mary McFarland; Matthew Kliethermes; Dallas Shi; Christina A Mamalis; Tom Greene; Christopher J Rudnisky; Balamurali Krishna Ambati Journal: Br J Ophthalmol Date: 2018-01-11 Impact factor: 4.638
Authors: Frank A Bucci; Ruth E Evans; Loretta M Amico; Timothy W Morris; Angel T Fluet; Christine M Sanfilippo; Heleen H DeCory; Timothy L Comstock Journal: Clin Ophthalmol Date: 2015-05-13
Authors: Robert Rejdak; Tomasz Choragiewicz; Agnieszka Kalinowska; Michael J Koss; Piotr Ksiazek; Joanna Moneta-Wielgos; Ryszard Maciejewski; Anselm G Jünemann; Katarzyna Nowomiejska Journal: BMC Infect Dis Date: 2016-09-20 Impact factor: 3.090